首页> 外国专利> Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses and protect the vaccinated host against intracellular pathogens and cancer

Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses and protect the vaccinated host against intracellular pathogens and cancer

机译:古细菌作为无细胞疫苗的免疫调节载体,可诱导细胞毒性t淋巴细胞(ctl)反应并保护接种疫苗的宿主免受细胞内病原体和癌症的侵害

摘要

The invention provides methods and compositions useful for inducing major histocompatibility complex class-I (MHC-I)-restricted cytotoxic T lymphocyte (CTL) response in a mammalian host immunized with acellular (non-replicating) antigen. The methods comprise using a liposome, an archaeosome, comprising a polar lipid extract of an archaeobacterium as both immune modulator and carrier for the non-replicating antigen. In addition to a strong antigen-specific CTL response, the archaeosome adjuvant elicits CD4+ Th1, CD4+ Th2 (antibody), and memory responses to the acellular antigen in the vaccine composition. The invention provides methods for mounting a rapid, and a long lasting protective immunity in the vaccinated host against infections caused by intracellular pathogens, especially those that require the host to mount an antigen-specific CD8+ T cell immune response for the protection. The methods of the invention are also useful in, but not restricted to, vaccines for preventing or reducing growth of solid tumors.
机译:本发明提供了用于在用脱细胞(非复制)抗原免疫的哺乳动物宿主中诱导主要的组织相容性复合物I类(MHC-1)限制性细胞毒性T淋巴细胞(CTL)应答的方法和组合物。该方法包括使用脂质体,古细菌体,其包含古细菌的极性脂质提取物作为免疫调节剂和非复制抗原的载体。除强烈的抗原特异性CTL反应外,古细菌佐剂还引起疫苗组合物中CD4 + Th1,CD4 + Th2(抗体)和对脱细胞抗原的记忆反应。本发明提供了在疫苗接种的宿主中针对由细胞内病原体引起的感染,尤其是需要宿主对抗原进行保护的抗原特异性CD8 + T细胞免疫应答的那些感染,建立快速而持久的保护性免疫的方法。本发明的方法也可用于但不限于用于预防或减少实体瘤生长的疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号